MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

iRhythm Technologies Inc

Fermé

SecteurSoins de santé

125.12 2.18

Résumé

Variation du prix de l'action

24h

Actuel

Min

122.45

Max

127.65

Chiffres clés

By Trading Economics

Revenu

11M

5.6M

Ventes

16M

209M

Marge bénéficiaire

2.671

Employés

2,400

EBITDA

14M

16M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+54.47% upside

Dividendes

By Dow Jones

Prochains Résultats

30 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-754M

3.9B

Ouverture précédente

122.94

Clôture précédente

125.12

Score Technique

By Trading Central

Confiance

Bullish Evidence

iRhythm Technologies Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 avr. 2026, 20:26 UTC

Acquisitions, Fusions, Rachats

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 avr. 2026, 18:15 UTC

Principaux Événements d'Actualité

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 avr. 2026, 16:49 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 avr. 2026, 16:49 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 avr. 2026, 22:58 UTC

Résultats

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 avr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 avr. 2026, 20:52 UTC

Résultats

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 avr. 2026, 20:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 avr. 2026, 20:29 UTC

Résultats

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 avr. 2026, 20:11 UTC

Acquisitions, Fusions, Rachats

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 avr. 2026, 19:34 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

17 avr. 2026, 19:34 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 avr. 2026, 19:31 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 avr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17 avr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 avr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 avr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 avr. 2026, 18:57 UTC

Principaux Événements d'Actualité

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 avr. 2026, 18:53 UTC

Acquisitions, Fusions, Rachats

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 avr. 2026, 18:53 UTC

Acquisitions, Fusions, Rachats

UCB 2026 Rev Guidance Unchanged

17 avr. 2026, 18:52 UTC

Acquisitions, Fusions, Rachats

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 avr. 2026, 18:52 UTC

Acquisitions, Fusions, Rachats

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 avr. 2026, 18:14 UTC

Market Talk
Principaux Événements d'Actualité

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 avr. 2026, 18:00 UTC

Principaux Événements d'Actualité

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 avr. 2026, 18:00 UTC

Principaux Événements d'Actualité

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 avr. 2026, 17:31 UTC

Market Talk
Principaux Événements d'Actualité

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 avr. 2026, 17:26 UTC

Market Talk
Résultats

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparaison

Variation de prix

iRhythm Technologies Inc prévision

Objectif de Prix

By TipRanks

54.47% hausse

Prévisions sur 12 Mois

Moyen 189.4 USD  54.47%

Haut 254 USD

Bas 147 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

11 ratings

10

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

104.78 / 137.91Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat